Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders. - Wikidata - wikimedia - TriplyDB

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

http://www.wikidata.org/entity/Q33892786

about

Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system via the diazepam binding inhibitor Increased generation of cysteinyl leukotrienes in Kawasaki disease Peroxisomes, myelination, and axonal integrity in the CNS.A timeline of stable isotopes and mass spectrometry in the life sciences.Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis.Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria.Urinary metabolites of leukotriene B4 in the human subject.12- and 15-hydroxyeicosatetraenoic acid are excreted in the urine of peroxisome-deficient patients: evidence for peroxisomal metabolism in vivo.

P2860

Q21260342-2CD4ADFA-F8CE-467E-8B3D-F3E4F7942A26 Q34796249-07D25EB4-5C39-4598-A30D-88391769C0FA Q37576855-1F49264D-42BB-48EE-A3A0-FDC012824A55 Q38751581-485C450A-14F3-4D2B-8E1A-2BAD43FC7042 Q38859739-52101769-E7A5-437F-8A8E-EF600F4AEFD4 Q41996386-935404AE-0942-4208-BFBC-D68B1CD622DE Q44412878-AAC2F617-68DB-4462-9C34-26BC6D80333F Q55066678-C8CCBBCC-0AF6-41DD-8652-16A28A69D8F6

P2860

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

http://www.wikidata.org/entity/Q33892786

description

1993 nî lūn-bûn

@nan

1993 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի մարտին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

@ast

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

@en

type

label

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

@ast

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

@en

prefLabel

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

@ast

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

@en

P1433

Q33892786-59962FCF-C85E-4B96-9D09-A71D8CDD46CC

P1476

Q33892786-D9B9A00A-E12B-4029-902C-A237A280A443

P2093

Q33892786-19DA652B-B4E4-47F5-8330-9AE15C5B16A6

Q33892786-1AB869E3-3EBF-49DF-A0EB-846C9640B7EF

Q33892786-8544991D-CD5E-47BF-91DE-74FDA9F41738

Q33892786-B4DBF62D-849A-439A-A049-B1DD9FD7202A

Q33892786-B5EFD013-C4F2-44D2-80D9-F1A5C0B6C65C

Q33892786-BF0C1D4B-1763-40CE-A078-112ECF05CDE0

Q33892786-D6D08515-8837-4CEB-8212-E8C54E720381

Q33892786-E9B48DCF-F6D7-4F46-9BCC-9AEE42DB2074

P2860

Q33892786-0014F2EC-8A98-456D-9C7A-F3A484C53FAF

Q33892786-0C26F01C-A391-44CF-B476-373040C299D4

Q33892786-16C51332-0DBA-4A6D-BE36-1C219A480705

Q33892786-28EF93C5-900C-4B68-93B3-D5AFAACE43BC

Q33892786-2E57DAA8-6FEC-4D56-9E76-93F7DCBD4F7C

Q33892786-42A96DA7-4924-4B48-96F1-D6933E960B03

Q33892786-4C3F0D98-7362-475E-824D-60827FB88531

Q33892786-5F26876C-87C6-46B9-B4C4-81E7C136D099

Q33892786-6B432713-9F2F-4B11-8F45-C2A15F9A6FC3

Q33892786-6C4B321D-C0A9-421F-94EE-0F82EFCDA1A6

P304

Q33892786-54912A19-4C5E-4B12-A091-25F36AF3B6F0

P31

Q33892786-E1184C3B-C487-4FD2-BAA4-2AA12729300A

P356

Q33892786-81B3910F-4225-4F2B-B597-03F61BAB3F77

P407

Q33892786-97891FC8-1594-4A75-A826-E1CBEB8419EF

P433

Q33892786-4AE8B028-ED85-40EA-8E32-CA9BF88EA31E

P478

Q33892786-973FFB4C-EAF4-4B2F-BE1D-23FBF5D463BD

P577

Q33892786-724B64E3-E8A9-433A-8AA1-7E64AF7DBC23

P5875

Q33892786-C8234AF8-2217-486F-8F07-4728E14A99B3

P698

Q33892786-C53E0D25-BB18-4CF3-B0C1-FB8BC9283D99

P932

Q33892786-6B1CB829-C5A3-40B2-9419-B12192F79118

P356

P1433

Journal of Clinical Investigation

P1476

Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

@en

P2093

Fauler J

http://www.w3.org/2001/XMLSchema#string

Frölich JC

http://www.w3.org/2001/XMLSchema#string

Keppler D

http://www.w3.org/2001/XMLSchema#string

Lehmann WD

http://www.w3.org/2001/XMLSchema#string

Mayatepek E

http://www.w3.org/2001/XMLSchema#string

Schutgens RB

http://www.w3.org/2001/XMLSchema#string

Tsikas D

http://www.w3.org/2001/XMLSchema#string

Wanders RJ

http://www.w3.org/2001/XMLSchema#string

P2860

Omega-oxidation of cysteine-containing leukotrienes by rat-liver microsomes. Isolation and characterization of omega-hydroxy and omega-carboxy metabolites of leukotriene E4 and N-acetylleukotriene E4

Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism

The identification and formation of 20-aldehyde leukotriene B4

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

Leukotriene C: a slow-reacting substance from murine mastocytoma cells

Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.

A FAMILIAL SYNDROME OF MULTIPLE CONGENITAL DEFECTS.

Formation of cholic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid by rat liver peroxisomes.

Conversion of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid into cholic acid by rat liver peroxisomes.

P304

881-888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI116309

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

1993-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14749378

http://www.w3.org/2001/XMLSchema#string

P698

8450067

http://www.w3.org/2001/XMLSchema#string

P932

288040

http://www.w3.org/2001/XMLSchema#string